2020
Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma.
Gynecologic oncology
鈥�Research at a glance
Top areas of exploration
- Pregnancy , 14 publications
- Cell Line, Tumor , 10 publications
- Uterine Neoplasms , 8 publications
- Neoplasm Recurrence, Local , 7 publications
Research activity
My publications
Filter publications
81 publications
2020
In聽vitro and in聽vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma.
Gynecologic oncology
鈥�2020
Opsoclonus-ataxia syndrome and mature ovarian teratoma in an adolescent.
Gynecologic oncology reports
鈥�2020
Pelvic Pain and Apical Prolapse Surgery: A Population-Based Retrospective Cohort Study.
Female pelvic medicine & reconstructive surgery
鈥�2020
Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomas.
Oncotarget
鈥�